Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 22, 2023, titled "Press Release - Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta for Chemotherapy-Induced Neutropenia (CIN)".
Press Release Nov 22 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
Later from Aurobindo Pharma
- Press Release Nov 29 2023
- Press Release Nov 30 2023
- Press Release Dec 27 2023
- Press Release Feb 10 2024
- Press Release Feb 12 2024
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma